Bank of America Corp DE raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 27.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 2,397,727 shares of the medical research company’s stock after acquiring an additional 513,709 shares during the period. Bank of America Corp DE owned approximately 0.80% of Agilent Technologies worth $317,291,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Riverview Trust Co bought a new stake in shares of Agilent Technologies during the 1st quarter valued at $33,000. Glassman Wealth Services grew its holdings in shares of Agilent Technologies by 47.4% in the 4th quarter. Glassman Wealth Services now owns 230 shares of the medical research company’s stock valued at $37,000 after buying an additional 74 shares during the period. Bank of New Hampshire acquired a new position in shares of Agilent Technologies in the 1st quarter valued at $38,000. Penserra Capital Management LLC acquired a new position in shares of Agilent Technologies in the 1st quarter valued at $60,000. Finally, CVA Family Office LLC grew its holdings in shares of Agilent Technologies by 133.3% in the 1st quarter. CVA Family Office LLC now owns 595 shares of the medical research company’s stock valued at $79,000 after buying an additional 340 shares during the period.
Wall Street Analysts Forecast Growth
A has been the subject of several research analyst reports. Cowen boosted their price target on shares of Agilent Technologies to $160.00 in a report on Monday, August 22nd. StockNews.com raised shares of Agilent Technologies from a “buy” rating to a “strong-buy” rating in a report on Friday, August 26th. Wells Fargo & Company boosted their price target on shares of Agilent Technologies from $130.00 to $135.00 and gave the company an “equal weight” rating in a report on Wednesday, August 17th. Credit Suisse Group began coverage on Agilent Technologies in a report on Wednesday, August 24th. They set an “outperform” rating and a $165.00 target price for the company. Finally, Citigroup boosted their price target on Agilent Technologies from $140.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, August 17th. Four investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $151.31.
Insider Buying and Selling
Agilent Technologies Trading Up 0.6 %
NYSE A opened at $130.72 on Tuesday. The stock has a market capitalization of $38.70 billion, a price-to-earnings ratio of 29.59, a PEG ratio of 2.56 and a beta of 1.06. Agilent Technologies, Inc. has a 52 week low of $112.52 and a 52 week high of $174.35. The stock’s 50 day moving average price is $129.92 and its two-hundred day moving average price is $127.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.41 and a current ratio of 1.94.
Agilent Technologies (NYSE:A – Get Rating) last posted its quarterly earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.14. The firm had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.64 billion. Agilent Technologies had a return on equity of 28.46% and a net margin of 19.94%. The business’s quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.10 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.07 earnings per share for the current fiscal year.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.